Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

NCT04304300 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04304300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Completed
Start date
December 10, 2019
Completion date
June 15, 2024
Enrollment
80 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, grade ii, astrocytoma, grade iii, oligodendroglioma, oligodendroglioma, anaplastic